Elisenda Alari‐Pahissa

CD69 limits early inflammatory diseases associated with immune response to <i>Listeria monocytogenes</i> infection

Javier Vega‐Ramos, Elisenda Alari‐Pahissa, Juana del Valle-Mendoza et al. · Immunology and Cell Biology · 2010 · 45 citations · Full text

Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen–Containing Particles

María López‐Montañés, Elisenda Alari‐Pahissa, Jordi Sintes et al. · The Journal of Immunology · 2017 · 36 citations · Full text

Adaptations of Natural Killer Cells to Self-MHC Class I

Stéphanie Bessoles, Camille Grandclément, Elisenda Alari‐Pahissa et al. · Frontiers in Immunology · 2014 · 34 citations · Full text

Autoimmune Disease, Immune Cell Development, Medicine +14

Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR

Laura Notario, Elisenda Alari‐Pahissa, Almudena Albentosa et al. · Leukemia · 2018 · 32 citations · Full text

High Proliferation, Immunology, Immunologic Mechanism +4

Structural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory Properties

Jérôme Kerzerho, Esther Dawen Yu, Carolina Barra et al. · The Journal of Immunology · 2012 · 26 citations · Full text

Nkt Agonist, Inflammatory Lung Disease, Lung Inflammation +26